Finance

Lists
Why is 2566 down 7.14%?
Dive Deeper
2566:HKG
Hangzhou Jiuyuan Genetic Biopharm Co Ltd
HK$5.20
-7.14%
(-0.40) 1D
Oct 15, 4:08:33 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2566...
Open
HK$5.50
High
HK$5.50
Low
HK$5.20
Mkt. cap
1.23B
Avg. vol.
119.21K
Volume
19.40K
Dividend
1.26%
Quarterly dividend
HK$0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
6.59
52-wk high
HK$10.84
52-wk low
HK$4.60
EPS
HK$0.79
Shares outstanding
245.40M
No. of employees
2K
Open
HK$5.50
High
HK$5.50
Low
HK$5.20
Mkt. cap
1.23B
Avg. vol.
119.21K
Volume
19.40K
Dividend
1.26%
Quarterly dividend
HK$0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
6.59
52-wk high
HK$10.84
52-wk low
HK$4.60
EPS
HK$0.79
Shares outstanding
245.40M
No. of employees
2K
News stories
From web sources and news partners
About Hangzhou Jiuyuan Genetic Biopharm Co Ltd
CEO-
Employees1.79K
Founded1993
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
333.76M
333.76M
315.48M
315.48M
Cost of goods sold
69.34M
69.34M
59.51M
59.51M
Cost of revenue
69.34M
69.34M
59.51M
59.51M
Research and development expenses
37.02M
37.02M
34.65M
34.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
205.11M
205.11M
169.86M
169.86M
Operating expense
239.33M
239.33M
205.22M
205.22M
Total operating expenses
308.67M
308.67M
264.72M
264.72M
Operating income
25.09M
25.09M
50.75M
50.75M
Other non operating income
3.53M
3.53M
1.28M
1.28M
EBT including unusual items
28.63M
28.63M
52.04M
52.04M
EBT excluding unusual items
28.63M
28.63M
52.04M
52.04M
Income tax expense
4.51M
4.51M
6.41M
6.41M
Effective tax rate
15.77%
15.77%
12.31%
12.31%
Other operating expenses
-2.80M
-2.80M
712.50K
712.50K
Net income
24.12M
24.12M
45.63M
45.63M
Net profit margin
7.23%
7.23%
14.47%
14.47%
Earnings per share
-
-
-
-
Interest and investment income
1.38M
1.38M
1.43M
1.43M
Interest expense
-1.49M
-1.49M
-1.42M
-1.42M
Net interest expenses
-106.00K
-106.00K
8.00K
8.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
32.68M
32.68M
61.50M
61.50M
Gain or loss from assets sale
29.00K
29.00K
4.00K
4.00K
AI content may include mistakes. Learn more
Google apps